Pfizer raises full-year outlook, stock rises on Q1 beat

Pfizer (PFE) shares tick up in pre-market trading — continuing into the green after the market open — after the pharmaceutical giant raised its full-year profit outlook and topped first-quarter earnings estimates on the top and bottom lines.

Yahoo Finance Health Reporter Anjalee Khemlani joins The Morning Brief to discuss Pfizer's outlook on its future product pipeline.

For more expert insight and the latest market action, click here to watch this full episode of Morning Brief.

This post was written by Luke Carberry Mogan.